References
1. Rickinson AB. Co-infections, inflammation and oncogenesis: future
directions for EBV research. Semin Cancer Biol. 2014;26:99-115.
2. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer
Res. 2004;10(3):803-21.
3. Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative
disorders. Hum Pathol. 2007;38(9):1293-304.
4. Greaves M. Infection, immune responses and the aetiology of childhood
leukaemia. Nat Rev Cancer. 2006;6(3):193-203.
5. Behrns KE, Sarr MG, Strickler JG. Pancreatic Lymphoma: Is It a
Surgical Disease? Pancreas. 1994;9(5):662-7.
6. Alvaro F, Jain M, Morris LL, et al. Childhood acute lymphoblastic
leukaemia presenting as jaundice. J Paediatr Child Health.
1996;32(5):466-8.
7. Shimamura R, Ishibashi H, Morioka E, et al. Assessment of abdominal
involvement of adult T-cell leukemia/lymphoma by ultrasonography:
comparison among four clinical types. J Clin Ultrasound.
1991;19(8):485-92.
8. Siddique MN, Popalzai M, Aoun N, et al. Precursor B-cell acute
lymphoblastic leukemia presenting as obstructive jaundice: a case
report. J Med Case Rep. 2011;5:269.
9. Mori T, Sugita K-i, Suzuki T, et al. Histopathologic features of the
biopsied liver at onset of childhood B-precursor acute lymphoblastic
leukemia presenting as severe jaundice. Journal of pediatric
gastroenterology and nutrition. 1997;25(3):354-7.
10. Devictor D, Tahiri C, Fabre M, et al. Early pre-B acute
lymphoblastic leukemia presenting as fulminant liver failure. Journal of
pediatric gastroenterology and nutrition. 1996;22(1):103-6.
11. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. The
Lancet. 2013;381(9881):1943-55.
12. Vallacha A, Haider G, Raja W, et al. Remission rate of acute
lymphoblastic leukemia (ALL) in adolescents and young adults (AYA).
Journal of the College of Physicians and Surgeons Pakistan.
2018;28(2):118-22.
13. Ward E, DeSantis C, Robbins A, et al. Childhood and adolescent
cancer statistics, 2014. CA: a cancer journal for clinicians.
2014;64(2):83-103.
14. Litten JB, Rodríguez MM, Maniaci V. Acute lymphoblastic leukemia
presenting in fulminant hepatic failure. Pediatric blood & cancer.
2006;47(6):842-5.
15. Heincelman M, Karakala N, Rockey DC. Acute lymphoblastic leukemia in
a young adult presenting as hepatitis and acute kidney injury. Journal
of investigative medicine high impact case reports.
2016;4(3):2324709616665866.
16. Ödemiş B, Parlak E, Başar Ö, et al. Biliary Tract Obstruction
Secondary to Malignant Lymphoma: Experience at a Referral Center.
Digestive Diseases and Sciences. 2007;52(9):2323-32.
17. Kader A, Vara R, Egberongbe Y, et al. Leukaemia presenting with
fulminant hepatic failure in a child. European journal of pediatrics.
2004;163(10):628-9.
18. Kelleher JF, Monteleone PM, Steele DA, et al. Hepatic dysfunction as
the presenting feature of acute lymphoblastic leukemia. Journal of
pediatric hematology/oncology. 2001;23(2):117-21.
19. Rajesh G, Sadasivan S, Hiran K, et al. Acute myeloid leukemia
presenting as obstructive jaundice. Indian Journal of Gastroenterology:
Official Journal of the Indian Society of Gastroenterology.
2006;25(2):93-4.
20. Comeau TB, Phillips DL. Chemotherapy dosing with elevated liver
function test results in acute leukemia. Annals of Pharmacotherapy.
2005;39(10):1752-4.
21. Takamatsu T. Preferential infiltration of liver sinusoids in acute
lymphoblastic leukemia. [Rinsho Ketsueki] The Japanese Journal of
Clinical Hematology. 2001;42(12):1181-6.
22. Schäfer G, Blumenthal MJ, Katz AA. Interaction of human tumor
viruses with host cell surface receptors and cell entry. Viruses.
2015;7(5):2592-617.
23. Straus SE, Cohen JI, Tosato G, et al. Epstein-Barr virus infections:
biology, pathogenesis, and management. Annals of internal medicine.
1993;118(1):45-58.
24. Lu Y, Sun L-R, Pang X-Y, et al. Infection status and clinical
significance of Epstein-Barr virus in pediatric leukemia—a report
of 35 cases. Ai Zheng= Aizheng= Chinese Journal of Cancer.
2007;26(1):54-7.
25. Sehgal S, Mujtaba S, Gupta D, et al. High incidence of Epstein Barr
virus infection in childhood acute lymphocytic lukemia: A preliminary
study. Indian journal of pathology and microbiology. 2010;53(1):63.
26. Young LS, Rickinson AB. Epstein–Barr virus: 40 years on. Nature
Reviews Cancer. 2004;4(10):757-68.
27. Parkin DM. The global health burden of infection‐associated cancers
in the year 2002. International journal of cancer. 2006;118(12):3030-44.
28. Ateyah ME, Hashem ME, Abdelsalam M. Epstein–Barr virus and
regulatory T cells in Egyptian paediatric patients with acute B
lymphoblastic leukaemia. Journal of Clinical Pathology.
2017;70(2):120-5.
29. Cohen JI. Epstein–Barr virus infection. New England journal of
medicine. 2000;343(7):481-92.
30. Williams H, Crawford DH. Epstein-Barr virus: the impact of
scientific advances on clinical practice. Blood. 2006;107(3):862-9.
31. Lehtinen M, Koskela P, Ögmundsdottir HM, et al. Maternal herpesvirus
infections and risk of acute lymphoblastic leukemia in the offspring.
American journal of epidemiology. 2003;158(3):207-13.
32. Ahmed HG, Osman SI, Ashankyty IM. Incidence of Epstein-Barr Virus in
Pediatric Leukemia in the Sudan. Clinical Lymphoma Myeloma and Leukemia.
2012;12(2):127-31.
33. Loutfy SA, El-Din HA, Ibrahim MF, et al. Seroprevalence of herpes
simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus in
children with acute lymphoblastic leukemia in Egypt. Saudi medical
journal. 2006;27(8):1139.
34. Mahjour SB, Ghaffarpasand F, Fattahi MJ, et al. Seroprevalence of
human herpes simplex, hepatitis B and epstein-barr viruses in children
with acute lymphoblastic leukemia in southern iran. Pathology &
Oncology Research. 2010;16(4):579-82.